- Report
- September 2024
- 82 Pages
India
From €3340EUR$3,500USD£2,799GBP
- Report
- November 2023
- 81 Pages
France
From €3340EUR$3,500USD£2,799GBP
- Report
- October 2023
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2023
- 79 Pages
Saudi Arabia
From €3340EUR$3,500USD£2,799GBP
- Report
- December 2023
- 140 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- June 2019
- 144 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- August 2022
- 120 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2024
- 70 Pages
Australia
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 75 Pages
France
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 190 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 81 Pages
Sweden
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 60 Pages
China
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 120 Pages
Asia Pacific
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 75 Pages
Canada
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 70 Pages
Spain
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 90 Pages
Netherlands
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 65 Pages
India
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 80 Pages
Italy
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 85 Pages
South Korea
From €4533EUR$4,750USD£3,798GBP

Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD.
Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients.
The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive.
Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more